↓ Skip to main content

COVIDOSE: Low-dose tocilizumab in the treatment of Covid-19

Overview of attention for article published in medRxiv
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (95th percentile)
  • Good Attention Score compared to outputs of the same age and source (69th percentile)

Mentioned by

news
4 news outlets
twitter
75 tweeters

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
55 Mendeley
Title
COVIDOSE: Low-dose tocilizumab in the treatment of Covid-19
Published in
medRxiv
DOI 10.1101/2020.07.20.20157503
Pubmed ID
Authors

Strohbehn, Garth W, Heiss, Brian L, Rouhani, Sherin J, Trujillo, Jonathan A, Yu, Jovian, Kacew, Alec J, Higgs, Emily F, Bloodworth, Jeffrey C, Cabanov, Alexandra, Wright, Rachel C, Koziol, Adriana, Weiss, Alexandra, Danahey, Keith, Karrison, Theodore G, Edens, Cuoghi C, Ventura, Iazsmin Bauer, Pettit, Natasha N, Patel, Bhakti, Pisano, Jennifer, Strek, Mary E, Gajewski, Thomas F, Ratain, Mark J, Reid, Pankti D

Twitter Demographics

The data shown below were collected from the profiles of 75 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 55 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 55 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 12 22%
Researcher 6 11%
Other 5 9%
Student > Master 5 9%
Student > Ph. D. Student 5 9%
Other 12 22%
Unknown 10 18%
Readers by discipline Count As %
Medicine and Dentistry 21 38%
Biochemistry, Genetics and Molecular Biology 6 11%
Pharmacology, Toxicology and Pharmaceutical Science 5 9%
Nursing and Health Professions 4 7%
Immunology and Microbiology 3 5%
Other 7 13%
Unknown 9 16%

Attention Score in Context

This research output has an Altmetric Attention Score of 73. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 November 2020.
All research outputs
#342,292
of 17,136,794 outputs
Outputs from medRxiv
#1,545
of 17,304 outputs
Outputs of similar age
#12,275
of 300,834 outputs
Outputs of similar age from medRxiv
#258
of 832 outputs
Altmetric has tracked 17,136,794 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 17,304 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 54.8. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 300,834 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 832 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.